Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $29,996 - $33,783
218 New
218 $33,000
Q2 2021

Jul 30, 2021

BUY
$105.21 - $117.21 $22,935 - $25,551
218 New
218 $25,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track 4 Thought Financial Group Inc. Portfolio

Follow 4 Thought Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 4 Thought Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on 4 Thought Financial Group Inc. with notifications on news.